New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;CRDC;GE;SYK;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
February 17, 2015
17:02 EDTSYKSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
09:29 EDTMDTMedtronic says FY16 constant currency revenue may be up mid-single digit range
Subscribe for More Information
09:27 EDTMDTMedtronic, Covidien targeting over $850M in cost synergies through FY18
Subscribe for More Information
08:49 EDTMDTMedtronic sees being at high end of Q4 revenue growth range
Subscribe for More Information
07:19 EDTMDTMedtronic sees Q4 revenue up 4%-6%
Subscribe for More Information
07:18 EDTMDTMedtronic reports Q3 EPS $1.01, consensus 97c
Subscribe for More Information
February 16, 2015
13:59 EDTMDTMedtronic receives expanded indications of the Vertex Reconstruction System
Subscribe for More Information
12:30 EDTMDTMedtronic announces CE mark, European launch of the Euphora catheter
Subscribe for More Information
February 15, 2015
15:42 EDTGEGE inaugurates new Indian manufacturing facility, Reuters says
General Electric inaugurated its new manufacturing facility in India this weekend that the conglomerate will use as an export hub, with plans to send half of its output to the company's global factories, says Reuters. The new Indian facility will be a major part of GE's plan to win increased domestic orders there, added Reuters. Reference Link
February 13, 2015
16:58 EDTAETGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
07:45 EDTSYKStryker would need at least $45 per share to buy Smith & Nephew, says Canaccord
Canaccord believes any deal for Stryker (SYK) to buy Smith & Nephew (SNN) would take at least $45 per share to get done and would most likely require cash and stock. The firm believes a deal would also require certain divestitures to appease regulators and would most likely impact the sports medicine and endoscopy businesses. Canaccord reiterated its Buy rating and $102 price target on Stryker shares.
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use